Search clinical trials for: Dendritic cell vaccination

Total 51571 results

Clinica Universidad de Navarra, Universidad de...
Centro de Investigación Médica Aplicada (CIMA)

Terminated

Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C

Hepatitis C, Chronic
John Kirkwood
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Dendritic Cells (DC) Vaccine for Metastatic Melanoma

Metastatic Melanoma

United States
Baylor Research Institute
Mary Crowley Medical Research Center; ODC Therapy

Completed

Vaccination of Patients With Stage IV Melanoma With Dendritic Cells

Melanoma | Neoplasm Metastasis

United States
Baylor Research Institute
French National Agency for Research on AIDS and Viral Hepatitis

Completed

Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)

HIV

United States
Baylor Research Institute

Withdrawn

Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.

Lymphoma
Radboud University Medical Center

Completed

Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients

Melanoma

Netherlands
Radboud University Medical Center

Completed

Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients

Melanoma

Netherlands
Beth Israel Deaconess Medical Center
Genzyme, a Sanofi Company

Completed

A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma

Renal Cell Carcinoma

United States
University of Pennsylvania

Completed

Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma

Melanoma

United States
Medical University of South Carolina

Completed

A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma Non-resectable

United States
Carolyn Britten
Oncovir, Inc.

Completed

A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma

Metastatic Pancreatic Cancer

United States
Hamilton Health Sciences Corporation
McMaster University

Completed

A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1 (MUC1)

Prostate Cancer

Canada
Inge Marie Svane

Completed

Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer

Prostatic Neoplasms

Denmark
Nantes University Hospital

Unknown

Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM) (CD lam)

Acute Myelogenous Leukemia

France
Washington University School of Medicine

Withdrawn

Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Carcinoma, Non-Small-Cell-Lung
Clinica Universidad de Navarra, Universidad de...
National Institutes of Health (NIH); Spanish Clinical Research Network - SCReN

Completed

Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer

Stage II Breast Cancer | Stage III Breast Cancer

Spain
Radboud University Medical Center

Completed

Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients

Melanoma

Netherlands
University of Michigan Rogel Cancer Center

Terminated

A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma

Metastatic Pancreatic Carcinoma

United States
Medical University of South Carolina

Terminated

Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells

Melanoma

United States
Cantonal Hospital of St. Gallen

Completed

Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer

Cancer of the Prostate
Duke University

Terminated

Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma

Metastatic Melanoma

United States
Clinica Universidad de Navarra, Universidad de...

Completed

Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection

Glioblastoma Multiforme

Spain
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Dendritic Cell Vaccination During Lymphoid Reconstruction

Intraocular Melanoma | Melanoma (Skin)

United States
Prof. Dr. Silke Gillessen

Terminated

Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma

Melanoma

Switzerland
University Hospital, Antwerp

Unknown

Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma

Acute Myeloid Leukemia | Multiple Myeloma | Chronic Myeloid Leukemia

Belgium
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Efficacy and Safety of Endoscopic Ultrasound Guided Fine-needle Injection of Dendritic Cells Vaccination Into Unresectable Pancreatic Cancer (DC)

Pancreatic Cancer

China
Cedars-Sinai Medical Center

Completed

Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients (Gliadel Wafer)

Malignant Glioma

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer

Small Cell Lung Cancer

United States
Hamilton Health Sciences Corporation
McMaster University; Canadian Breast Cancer Research Alliance; Ontario Cancer...

Completed

Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2

Breast Neoplasms

Canada
Quantum Immunologics, Inc.
University of South Alabama

Unknown

Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer

Breast Cancer

United States
Erasmus Medical Center

Completed

Dendritic Cell-based Immunotherapy in Mesothelioma

Malignant Pleural Mesothelioma

Netherlands
University of Arkansas

Completed

Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally

Multiple Myeloma

United States
University Hospital, Antwerp

Completed

Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission (CCRG 05-001)

Acute Myeloid Leukemia (AML)

Belgium
University Hospital Carl Gustav Carus

Completed

Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma

Multiple Myeloma | Plasmocytoma

Germany
Southern Cancer Center
University of South Alabama; Quantum Immunologics, Inc.

Unknown

A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Statens Serum Institut
Rigshospitalet, Denmark; Hvidovre University Hospital

Completed

Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection (HIVDCVac)

HIV Infections

Denmark
Radboud University Medical Center
Dutch Cancer Society

Completed

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Melanoma Stage III or IV

Netherlands
University Hospital, Gentofte, Copenhagen

Completed

Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer

Colorectal Neoplasms

Denmark
Mackay Memorial Hospital

Unknown

Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection

Neoplasms

Taiwan
National Institute of Allergy and Infectious Diseases...

Completed

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

HIV Infections

United States
José Mordoh, M.D., Ph.D.

Completed

Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells

Melanoma

Argentina
Institut de Recherches Internationales Servier
Servier Bio-Innovation LLC

Not yet recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation (PyramIDH)

Myelodysplastic Syndromes (MDS) | Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS)
Massachusetts General Hospital
National Cancer Institute (NCI); Fred Hutchinson Cancer Center; University of... and other collaborators

Not yet recruiting

Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV. (HOPE II)

Hiv | Human Papilloma Virus
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

Breast Cancer | Triple Negative Breast Cancer

United States
Shenzhen Geno-Immune Medical Institute
The No.2 Clinical Hospital of the Ministry of Health

Recruiting

Engineered Dendritic Cell Vaccines for Multiple Myeloma

Multiple Myeloma or Plasmacytoma

China, Russian Federation
Tufts Medical Center
Boston Medical Center; Northeastern University

Not yet recruiting

Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV) Clinical Trial

Human Papilloma Virus

United States
Sinovac Biotech Co., Ltd

Not yet recruiting

Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers

Poliomyelitis
Ashutosh Kumar Tewari
Oncovir, Inc.

Recruiting

Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance

Prostate Cancer Patients on Active Surveillance

United States
Jonsson Comprehensive Cancer Center

Not yet recruiting

A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma

Diffuse Hemispheric Glioma, H3 G34-Mutant

United States

3

Subscribe